It develops Vonoprazan, a potassium-competitive acid blocker. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is ...

The US regulator has cleared two therapies based on Phathom's acid blocker vonoprazan in combination with antibiotics for Helicobacter pylori infections , which are associated with peptic ulcer ...

Pharmaceutical company Lupin has announced a non-exclusive patent licence agreement with Takeda Pharmaceutical for the ...

Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on Phathom Pharmaceuticals (PHAT – Research Report) on November 8 and set ...

A third option consists of a new, highly potent drug called vonoprazan, combined with the antibiotic amoxicillin, that blocks ...

New Delhi: Hetero Labs has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard ...

Our Bureau, New Delhi Wednesday, November 6, 2024, 13:45 Hrs [IST] Dr Reddy's Laboratories has reported a decline of 9.36 pe ...

Other medications can affect the removal of vonoprazan from your body, which may affect how vonoprazan works. Examples include rifamycins (such as rifabutin), among others. Do not share this ...

H. pylori test and treat in case of unexplained iron deficiency anemia n.m. n.m. H. pylori test and treat in case of idiopathic thrombocytopenic purpura n.m. n.m. MALToma: Mucosa-associated ...

At Mar-a-Lago, ‘Uncle’ Elon Musk Puts His Imprint on the Trump Transition He’s on the patio. He’s on the golf course. Everywhere President-elect Trump looks, there is the world’s richest ...

Gastric Cancer e-Tumor Boards: Case 4: Superficial Adenocarcinoma This case focuses on a 76-year-old gentleman with a history of colonic adenocarcinoma who underwent sigmoidoscopy in the past.